# Seelos Therapeutics
 (stock symbol: SEEL) Logo in transparent PNG and SVG formats

## Seelos Therapeutics
 Logo large

### Seelos Therapeutics
 Logo large Download PNG (57.31 KB)

![Seelos Therapeutics
 Logo large Download PNG (57.31 KB)](/img/orig/SEEL_BIG-6c02095e.png)

### Seelos Therapeutics
 Logo large Download SVG (11.34 KB)

![Seelos Therapeutics
 Logo large Download SVG (11.34 KB)](/img/orig/SEEL_BIG-ae9cfe36.svg)

## Seelos Therapeutics
 Logo icon format

### Seelos Therapeutics
 Logo icon format Download PNG (59.95 KB)

![Seelos Therapeutics
 Logo icon format Download PNG (59.95 KB)](/img/orig/SEEL-fbc167d3.png)

### Seelos Therapeutics
 Logo icon format Download SVG (2.98 KB)

![Seelos Therapeutics
 Logo icon format Download SVG (2.98 KB)](/img/orig/SEEL-b1c7a7ae.svg)

## About Seelos Therapeutics


Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD). Its preclinical programs include SLS-007, an anti-alpha-synuclein peptidic inhibitor to treat patients with PD; SLS-008, an orally available antagonist for chemoattractant receptor-homologous molecule for the treatment of chronic inflammation in asthma and pediatric orphan indications; SLS-004 for the treatment of PD; SLS-010, an oral histamine H3A receptor antagonist for narcolepsy and related disorders; and SLS-012, an injectable therapy for post-operative pain management. Seelos Therapeutics, Inc. was incorporated in 1987 and is headquartered in New York, New York.

1. Website domain: seelostherapeutics.com
2. Employees: 15
3. Marketcap: $84.06 Million USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
